Skip to content
TrialScanner

NCT00323856

Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

Phase 4CompletedGRFSLead

Registry record

Lead sponsor
Grifols Biologicals, LLC
Conditions
Severe Hemophilia A
Primary completion
Dec 11, 2018Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00323856 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00323856: Safety Study of Alphanate in... | TrialScanner